 Home > Active Ingredient News > Immunology News > Med J Aust: Opioid therapy may be suboptimal for pain relief in patients with osteoarthritis

Med J Aust: Opioid therapy may be suboptimal for pain relief in patients with osteoarthritis

 Last Update: 2022-05-15
 Source: Internet
 Author: User

Tags

atbs reviews

adp 2 0

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Osteoarthritis affects more than 500 million people worldwide and is one of the leading causes of disability

We searched MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews and the Central Register of Controlled Trials, CINAHL, PsycINFO, AMED and the WHO International Clinical Trials Registry for published trials up to 31 October 2020

We extracted data on pain, disability, health-related quality of life, and adverse events from 36 eligible trials (total dose range, 10-210 mg morphine equivalent per day [MME])

RESULTS: Results from 19 trials (including 8965 participants; dose range, 10-126 MME/day) showed a small benefit of opioids for mid-term pain relief (mean difference [MD], -4.

Taken together, the findings suggest that opioids may provide very small pain relief and disability benefits for patients with osteoarthritis, but may also increase the risk of adverse events

Original source:

Christina Abdel Shaheed, et al.

leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.